Skip to main content
Top
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Research article

Clinical characteristics of hospital-onset Pneumocystis pneumonia and genotypes of Pneumocystis jirovecii in a single tertiary centre in Korea

Authors: Tark Kim, Sang-Oh Lee, Hyo-Lim Hong, Ju Young Lee, Sung-Han Kim, Sang-Ho Choi, Mi-Na Kim, Yang Soo Kim, Jun Hee Woo, Heungsup Sung

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

Pneumocystis pneumonia (PCP) may develop as a clinical manifestation of nosocomial pneumonia by means of either reactivation of resident P. jirovecii or de novo infection. However, there have been no studies describing the clinical characteristics of hospital-onset PCP.

Methods

A retrospective review of medical records was performed to identify episodes of hospital-onset PCP in a tertiary care centre in Korea between May 2007 and January 2013. We investigated whether human-to-human contact during hospitalisation contributed to PCP development by molecular analysis of the genes encoding mitochondrial large ribosomal subunit (mtLSU) rRNA and dihydropteroate synthase (DHPS) and a review of hospitalisation history.

Results

During the study period, 129 patients (130 episodes) were diagnosed with PCP. Of these, respiratory specimens from 94 patients during 95 PCP episodes were available for analysis. Sixteen episodes (16.8%) were categorised as hospital-onset PCP. There was a trend toward a higher proportion of haematological malignancy (43.8% [7/16] vs. 20.3% [16/79]; P = 0.058) in patients with hospital-onset PCP compared to patients with community-onset PCP. mtLSU genotype 1 was the most common, occurring in 41 (43.2%) patients. There were four possible cases of nosocomial transmission. Mutation in DHPS was not observed in any PCP episode.

Conclusions

PCP can be one of the causes of nosocomial pneumonia, although the mode of acquisition and transmission of P. jirovecii remains uncertain. mtLSU genotype 1 is the predominant P. jirovecii strain in Korea.
Literature
1.
go back to reference Hughes WT. Natural mode of acquisition for de novo infection with Pneumocystis carinii. J Infect Dis. 1982;145(6):842–8.CrossRefPubMed Hughes WT. Natural mode of acquisition for de novo infection with Pneumocystis carinii. J Infect Dis. 1982;145(6):842–8.CrossRefPubMed
2.
go back to reference Vargas SL, Hughes WT, Santolaya ME, Ulloa AV, Ponce CA, Cabrera CE, et al. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis. 2001;32(6):855–61.CrossRefPubMed Vargas SL, Hughes WT, Santolaya ME, Ulloa AV, Ponce CA, Cabrera CE, et al. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis. 2001;32(6):855–61.CrossRefPubMed
3.
go back to reference Frenkel JK, Good JT, Shultz JA. Latent Pneumocystis infection of rats, relapse, and chemotherapy. Lab Invest. 1966;15(10):1559–77.PubMed Frenkel JK, Good JT, Shultz JA. Latent Pneumocystis infection of rats, relapse, and chemotherapy. Lab Invest. 1966;15(10):1559–77.PubMed
4.
go back to reference Garvy BA, Harmsen AG. Susceptibility to Pneumocystis carinii infection: host responses of neonatal mice from immune or naive mothers and of immune or naive adults. Infect Immun. 1996;64(10):3987–92.PubMedPubMedCentral Garvy BA, Harmsen AG. Susceptibility to Pneumocystis carinii infection: host responses of neonatal mice from immune or naive mothers and of immune or naive adults. Infect Immun. 1996;64(10):3987–92.PubMedPubMedCentral
5.
go back to reference Huang L, Beard CB, Creasman J, Levy D, Duchin JS, Lee S, et al. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J Infect Dis. 2000;182(4):1192–8.CrossRefPubMed Huang L, Beard CB, Creasman J, Levy D, Duchin JS, Lee S, et al. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J Infect Dis. 2000;182(4):1192–8.CrossRefPubMed
6.
go back to reference Gianella S, Haeberli L, Joos B, Ledergerber B, Wuthrich RP, Weber R, et al. Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients. Transpl Infect Dis. 2010;12(1):1–10.CrossRefPubMed Gianella S, Haeberli L, Joos B, Ledergerber B, Wuthrich RP, Weber R, et al. Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients. Transpl Infect Dis. 2010;12(1):1–10.CrossRefPubMed
7.
go back to reference Damiani C, Choukri F, Le Gal S, Menotti J, Sarfati C, Nevez G, et al. Possible nosocomial transmission of Pneumocystis jirovecii. Emerg Infect Dis. 2012;18(5):877–8.CrossRefPubMedPubMedCentral Damiani C, Choukri F, Le Gal S, Menotti J, Sarfati C, Nevez G, et al. Possible nosocomial transmission of Pneumocystis jirovecii. Emerg Infect Dis. 2012;18(5):877–8.CrossRefPubMedPubMedCentral
8.
go back to reference Sassi M, Ripamonti C, Mueller NJ, Yazaki H, Kutty G, Ma L, et al. Outbreaks of Pneumocystis pneumonia in 2 renal transplant centers linked to a single strain of Pneumocystis: implications for transmission and virulence. Clin Infect Dis. 2012;54(10):1437–44.CrossRefPubMedPubMedCentral Sassi M, Ripamonti C, Mueller NJ, Yazaki H, Kutty G, Ma L, et al. Outbreaks of Pneumocystis pneumonia in 2 renal transplant centers linked to a single strain of Pneumocystis: implications for transmission and virulence. Clin Infect Dis. 2012;54(10):1437–44.CrossRefPubMedPubMedCentral
9.
go back to reference Schmoldt S, Schuhegger R, Wendler T, Huber I, Sollner H, Hogardt M, et al. Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation. J Clin Microbiol. 2008;46(3):966–71.CrossRefPubMedPubMedCentral Schmoldt S, Schuhegger R, Wendler T, Huber I, Sollner H, Hogardt M, et al. Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation. J Clin Microbiol. 2008;46(3):966–71.CrossRefPubMedPubMedCentral
10.
go back to reference Thomas S, Vivancos R, Corless C, Wood G, Beeching NJ, Beadsworth MB. Increasing frequency of Pneumocystis jirovecii pneumonia in renal transplant recipients in the United Kingdom: clonal variability, clusters, and geographic location. Clin Infect Dis. 2011;53(3):307–8.CrossRefPubMed Thomas S, Vivancos R, Corless C, Wood G, Beeching NJ, Beadsworth MB. Increasing frequency of Pneumocystis jirovecii pneumonia in renal transplant recipients in the United Kingdom: clonal variability, clusters, and geographic location. Clin Infect Dis. 2011;53(3):307–8.CrossRefPubMed
11.
go back to reference Nevez G, Chabe M, Rabodonirina M, Virmaux M, Dei-Cas E, Hauser PM, et al. Nosocomial Pneumocystis jirovecii infections. Parasite. 2008;15(3):359–65.CrossRefPubMed Nevez G, Chabe M, Rabodonirina M, Virmaux M, Dei-Cas E, Hauser PM, et al. Nosocomial Pneumocystis jirovecii infections. Parasite. 2008;15(3):359–65.CrossRefPubMed
12.
go back to reference Kollef MH, Silver P, Murphy DM, Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest. 1995;108(6):1655–62.CrossRefPubMed Kollef MH, Silver P, Murphy DM, Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest. 1995;108(6):1655–62.CrossRefPubMed
13.
go back to reference Beard CB, Carter JL, Keely SP, Huang L, Pieniazek NJ, Moura IN, et al. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis. 2000;6(3):265–72.CrossRefPubMedPubMedCentral Beard CB, Carter JL, Keely SP, Huang L, Pieniazek NJ, Moura IN, et al. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis. 2000;6(3):265–72.CrossRefPubMedPubMedCentral
14.
go back to reference Lane BR, Ast JC, Hossler PA, Mindell DP, Bartlett MS, Smith JW, et al. Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J Infect Dis. 1997;175(2):482–5.CrossRefPubMed Lane BR, Ast JC, Hossler PA, Mindell DP, Bartlett MS, Smith JW, et al. Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J Infect Dis. 1997;175(2):482–5.CrossRefPubMed
15.
go back to reference Wakefield AE, Pixley FJ, Banerji S, Sinclair K, Miller RF, Moxon ER, et al. Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol Biochem Parasitol. 1990;43(1):69–76.CrossRefPubMed Wakefield AE, Pixley FJ, Banerji S, Sinclair K, Miller RF, Moxon ER, et al. Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol Biochem Parasitol. 1990;43(1):69–76.CrossRefPubMed
16.
go back to reference Montes-Cano MA, de la Horra C, Martin-Juan J, Varela JM, Torronteras R, Respaldiza N, et al. Pneumocystis jiroveci genotypes in the Spanish population. Clin Infect Dis. 2004;39(1):123–8.CrossRefPubMed Montes-Cano MA, de la Horra C, Martin-Juan J, Varela JM, Torronteras R, Respaldiza N, et al. Pneumocystis jiroveci genotypes in the Spanish population. Clin Infect Dis. 2004;39(1):123–8.CrossRefPubMed
17.
go back to reference Hocker B, Wendt C, Nahimana A, Tonshoff B, Hauser PM. Molecular evidence of Pneumocystis transmission in pediatric transplant unit. Emerg 343. Infect Dis. 2005;11(2):330–2.CrossRef Hocker B, Wendt C, Nahimana A, Tonshoff B, Hauser PM. Molecular evidence of Pneumocystis transmission in pediatric transplant unit. Emerg 343. Infect Dis. 2005;11(2):330–2.CrossRef
18.
go back to reference Olsson M, Eriksson BM, Elvin K, Strandberg M, Wahlgren M. Genotypes of clustered cases of Pneumocystis carinii pneumonia. Scand J Infect Dis. 2001;33(4):285–9.CrossRefPubMed Olsson M, Eriksson BM, Elvin K, Strandberg M, Wahlgren M. Genotypes of clustered cases of Pneumocystis carinii pneumonia. Scand J Infect Dis. 2001;33(4):285–9.CrossRefPubMed
19.
go back to reference Rabodonirina M, Vanhems P, Couray-Targe S, Gillibert RP, Ganne C, Nizard N, et al. Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients. Emerg Infect Dis. 2004;10(10):1766–73.CrossRefPubMedPubMedCentral Rabodonirina M, Vanhems P, Couray-Targe S, Gillibert RP, Ganne C, Nizard N, et al. Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients. Emerg Infect Dis. 2004;10(10):1766–73.CrossRefPubMedPubMedCentral
20.
go back to reference de Boer MG, Bruijnesteijn van Coppenraet LE, Gaasbeek A, Berger SP, Gelinck LB, van Houwelingen HC, et al. An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? Clin Infect Dis. 2007;44(9):1143–9.CrossRefPubMed de Boer MG, Bruijnesteijn van Coppenraet LE, Gaasbeek A, Berger SP, Gelinck LB, van Houwelingen HC, et al. An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? Clin Infect Dis. 2007;44(9):1143–9.CrossRefPubMed
21.
go back to reference Yazaki H, Goto N, Uchida K, Kobayashi T, Gatanaga H, Oka S. Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host. Transplantation. 2009;88(3):380–5.CrossRefPubMed Yazaki H, Goto N, Uchida K, Kobayashi T, Gatanaga H, Oka S. Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host. Transplantation. 2009;88(3):380–5.CrossRefPubMed
22.
go back to reference Matsumura Y, Shindo Y, Iinuma Y, Yamamoto M, Shirano M, Matsushima A, et al. Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes. BMC Infect Dis. 2011;11:76.CrossRefPubMedPubMedCentral Matsumura Y, Shindo Y, Iinuma Y, Yamamoto M, Shirano M, Matsushima A, et al. Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes. BMC Infect Dis. 2011;11:76.CrossRefPubMedPubMedCentral
23.
go back to reference Gupta R, Mirdha BR, Guleria R, Agarwal SK, Samantaray JC, Kumar L, et al. Genotypic variation of Pneumocystis jirovecii isolates in India based on sequence diversity at mitochondrial large subunit rRNA. Int J Med Microbiol. 2011;301(3):267–72.CrossRefPubMed Gupta R, Mirdha BR, Guleria R, Agarwal SK, Samantaray JC, Kumar L, et al. Genotypic variation of Pneumocystis jirovecii isolates in India based on sequence diversity at mitochondrial large subunit rRNA. Int J Med Microbiol. 2011;301(3):267–72.CrossRefPubMed
24.
go back to reference Jarboui MA, Mseddi F, Sellami H, Sellami A, Makni F, Ayadi A. Genetic diversity of Pneumocystis jirovecii strains based on sequence variation of different DNA region. Med Mycol. 2013;51(6):561–7.CrossRefPubMed Jarboui MA, Mseddi F, Sellami H, Sellami A, Makni F, Ayadi A. Genetic diversity of Pneumocystis jirovecii strains based on sequence variation of different DNA region. Med Mycol. 2013;51(6):561–7.CrossRefPubMed
25.
go back to reference Rabodonirina M, Vaillant L, Taffe P, Nahimana A, Gillibert RP, Vanhems P, et al. Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia. Emerg Infect Dis. 2013;19(1):21–8. quiz 186.CrossRefPubMedPubMedCentral Rabodonirina M, Vaillant L, Taffe P, Nahimana A, Gillibert RP, Vanhems P, et al. Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia. Emerg Infect Dis. 2013;19(1):21–8. quiz 186.CrossRefPubMedPubMedCentral
26.
go back to reference Kim T, Moon SM, Sung H, Kim MN, Kim SH, Choi SH, et al. Outcomes of non-HIV-infected patients with Pneumocystis pneumonia and concomitant pulmonary cytomegalovirus infection. Scand J Infect Dis. 2012;44(9):670–7.CrossRefPubMed Kim T, Moon SM, Sung H, Kim MN, Kim SH, Choi SH, et al. Outcomes of non-HIV-infected patients with Pneumocystis pneumonia and concomitant pulmonary cytomegalovirus infection. Scand J Infect Dis. 2012;44(9):670–7.CrossRefPubMed
27.
go back to reference Kim T, Kim SH, Park KH, Cho OH, Sung H, Kim MN, et al. Clindamycin-primaquine versus pentamidine for the second-line treatment of pneumocystis pneumonia. J Infect Chemother. 2009;15(5):343–6.CrossRefPubMed Kim T, Kim SH, Park KH, Cho OH, Sung H, Kim MN, et al. Clindamycin-primaquine versus pentamidine for the second-line treatment of pneumocystis pneumonia. J Infect Chemother. 2009;15(5):343–6.CrossRefPubMed
28.
go back to reference Moon SM, Kim T, Sung H, Kim MN, Kim SH, Choi SH, et al. Outcomes of moderate-to-severe Pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients. Antimicrob Agents Chemother. 2011;55(10):4613–8.CrossRefPubMedPubMedCentral Moon SM, Kim T, Sung H, Kim MN, Kim SH, Choi SH, et al. Outcomes of moderate-to-severe Pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients. Antimicrob Agents Chemother. 2011;55(10):4613–8.CrossRefPubMedPubMedCentral
29.
go back to reference Maitte C, Leterrier M, Le Pape P, Miegeville M, Morio F. Multilocus sequence typing of Pneumocystis jirovecii from clinical samples: how many and which loci should be used? J Clin Microbiol. 2013;51(9):2843–9.CrossRefPubMedPubMedCentral Maitte C, Leterrier M, Le Pape P, Miegeville M, Morio F. Multilocus sequence typing of Pneumocystis jirovecii from clinical samples: how many and which loci should be used? J Clin Microbiol. 2013;51(9):2843–9.CrossRefPubMedPubMedCentral
Metadata
Title
Clinical characteristics of hospital-onset Pneumocystis pneumonia and genotypes of Pneumocystis jirovecii in a single tertiary centre in Korea
Authors
Tark Kim
Sang-Oh Lee
Hyo-Lim Hong
Ju Young Lee
Sung-Han Kim
Sang-Ho Choi
Mi-Na Kim
Yang Soo Kim
Jun Hee Woo
Heungsup Sung
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-0847-6

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine